Last updated: June 12, 2026
Jaimiess (levonorgestrel/ethinyl estradiol) suppliers and manufacturers: who makes the active ingredients, who fills, and what supply chain risks matter
Jaimiess is an oral contraceptive product containing levonorgestrel and ethinyl estradiol. Supplier visibility is typically split between (1) API makers for levonorgestrel (LNG) and ethinyl estradiol (EE), (2) contract manufacturing and packaging of the tablet blend and finished dosage form, and (3) labeler/distributor parties that hold the FDA listing and coordinate U.S. supply.
No verified supplier list is possible from the information provided.
What companies supply levonorgestrel (API) for Jaimiess?
Direct answer: A complete, verified roster of API suppliers for levonorgestrel used in Jaimiess cannot be produced without product-level source documentation.
How LNG API supply is typically structured
- LNG is manufactured under GMP by specialized API producers.
- Finished-product tablet manufacturing typically uses an NDA/ANDA-approved formulation and validated blending controls, so LNG source can vary by site and lot.
What companies supply ethinyl estradiol (API) for Jaimiess?
Direct answer: A complete, verified roster of API suppliers for ethinyl estradiol used in Jaimiess cannot be produced without product-level source documentation.
How EE API supply is typically structured
- EE API supply is concentrated in a smaller set of GMP-qualified manufacturers.
- Finished-product sites qualify incoming API by specification and testing.
Who manufactures Jaimiess tablets (contract manufacturer and fill-finish)?
Direct answer: A verified list of CMO fill-finish/packaging manufacturers for Jaimiess cannot be produced from the information provided.
What to look for in the supplier record
- Drug master file (DMF) references tied to the formulation and process
- Listing under the FDA National Drug Code directory (labeler name)
- Site-specific manufacturing/packaging described on FDA labels and regulatory submissions
Who is the labeler/distributor for Jaimiess in the U.S.?
Direct answer: A verified labeler/distributor identity cannot be stated from the information provided.
Why labeler identity matters for procurement
- Purchasing decisions are usually tied to the labeler or its authorized distributors
- Repackagers and wholesalers often differ from the manufacturing site
What supply chain disruptions or single-source risks exist for Jaimiess?
Direct answer: Specific single-source risks for Jaimiess cannot be determined without verified supplier and site data.
Risk points that commonly affect oral contraceptives
- LNG/EE API availability and compliance status
- Tablet compression, coating, and packaging line constraints
- Serialization and packaging component lead times
How does Jaimiess compare with generic levonorgestrel/ethinyl estradiol tablets on suppliers?
Direct answer: A supplier comparison versus generics cannot be completed without listing the competing products’ labelers and manufacturing sites.
Why supplier divergence is common
- Generic products may use different API suppliers and different tablet manufacturing sites
- Even when formulation is equivalent, process and packaging vendors often change
What information sources are used to identify true Jaimiess suppliers?
Direct answer: The supplier set must come from regulatory and packaging records; a definitive supplier list cannot be produced from the provided prompt.
Typical evidence used in supplier mapping
- FDA NDC Directory labeler/manufacturer fields
- FDA drug product label “Manufactured for / Distributed by” statements
- DMF-linked excipient/API references in submissions
- Importer of record and commercial documentation in procurement systems
Key Takeaways
- A verified supplier list for Jaimiess (API and finished-product manufacturing/packaging) cannot be produced from the information provided.
- Supplier mapping for an oral contraceptive requires FDA labeler/manufacturer and site-level records tied to the NDC and product labeling.
FAQs
- How can I identify the true manufacturer behind Jaimiess without guessing?
- Do levonorgestrel and ethinyl estradiol API suppliers differ across lots of Jaimiess?
- What does the NDC Directory show for Jaimiess labeler vs manufacturer?
- How do CMOs for oral contraceptives handle tablet compression and coating scale-up?
- What documentation do procurement teams request to qualify Jaimiess supply continuity?
References (APA)
- FDA. NDC Directory. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/scripts/cder/ndc/
- FDA. Drug Labeling Resources. U.S. Food and Drug Administration. https://www.fda.gov/drugs/drug-approvals-and-databases/drug-labels
